$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Bevacizumab and erlotinib combination effective in treating papillary renal cell carcinoma: NEJM
2026-02-01 22:25:32
Check Details
Are tofacitinib/Shangjie and tofacitinib citrate tablets the same?
2026-02-01 22:25:32
Check Details
FDA approves Treosulfan-Grafapex plus fludarabine as a preparation for adult and pediatric patients with acute myeloid leukemia or MDS undergoing allogeneic hematopoietic stem cell transplantation
2026-02-01 22:25:32
Check Details
What are the detailed instructions for cycloserine?
2026-02-01 22:25:32
Check Details
How many times a day do you need to take Linezolid/Siwo 600mg?
2026-02-01 22:25:32
Check Details
Which manufacturer is Ruibosili/Kaillon?
2026-02-01 22:25:32
Check Details
The relationship between Cemiplimab and Cemiplimab
2026-02-01 22:25:32
Check Details
Potential side effects and safety assessment of daprodustat
2026-02-01 22:25:32
Check Details
Platinib (Pujihua) complete Chinese instruction manual and important medication tips
2026-02-01 22:25:32
Check Details
The latest pricing policy and price adjustment trends of capmatinib in 2025
2026-02-01 22:25:32
Check Details
Which manufacturer is Sotoracib (AMG 510) produced by and its quality supervision status?
2026-02-01 22:25:32
Check Details
Which pharmaceutical company develops and manufactures adagrasib (Krazati)?
2026-02-01 22:25:32
Check Details
1
2
...
1922
1923
1924
1925
1926
1927
1928
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma